secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001193125-24-099824
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q1 diluted EPS $9.59 (+15.5%); raises FY2024 adj. EPS guidance to >$37.20
--------------------------------------------------------------------------------

- Q1 operating revenue $42.3B (+0.9% YoY); diluted EPS $9.59 (+15.5%); adjusted diluted EPS $10.64 (+12.5%).
- Benefit expense ratio 85.6%, improving 20 bps; operating margin 7.1% vs 6.8% YoY.
- Medical membership 46.2M, down 1.9M YoY due to Medicaid attrition, partially offset by commercial growth.
- Carelon revenue $12.1B (+5%); operating gain $0.8B (+10%).
- FY2024 guidance raised: diluted EPS >$34.05, adjusted >$37.20; strategic partnership with CD&R for primary care.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312524099824/0001193125-24-099824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312524099824/d813732d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-099824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer